Company News & Events

A new tool to fight cancer, infections, addiction

2024-03-13T16:27:48-04:00

A soccer ball-shaped, nanoparticle-sized vaccine delivery platform called Q-Beta might hold the key to unlocking treatments for any number of viruses and diseases — from cancers to infections and even opioid addiction — thanks to the work of a research team that got its start at Michigan State University.

A new tool to fight cancer, infections, addiction2024-03-13T16:27:48-04:00

Iaso Therapeutics Receives Grant from the National Science Foundation for Next-Generation Vaccine Research

2024-02-29T17:13:40-05:00

The nearly $1 million grant will fund vaccine delivery research targeting infectious diseases and cancer EAST LANSING, Mich., March 14, 2022 -- Iaso Therapeutics, a research program focused on [...]

Iaso Therapeutics Receives Grant from the National Science Foundation for Next-Generation Vaccine Research2024-02-29T17:13:40-05:00

Iaso Therapeutics Awarded Competitive Grant from the National Institute of Allergy and Infectious Diseases

2024-02-29T17:14:10-05:00

Small Business Innovation Research Program Provides Seed Funding for R&D East Lansing, MI, 07/15/2021 – Iaso Therapeutics, INC. has been awarded a National Institute of Allergy and Infectious Diseases [...]

Iaso Therapeutics Awarded Competitive Grant from the National Institute of Allergy and Infectious Diseases2024-02-29T17:14:10-05:00

Iaso Therapeutics Invited to TRECS Workshop

2024-02-29T17:15:32-05:00

East Lansing, MI – Iaso Therapeutics (Iaso) has received a selective invitation to participate in the National Cancer Institute (NCI) Translational Resources to Expedite Commercialization Success Workshop (TRECS WORKSHOP). [...]

Iaso Therapeutics Invited to TRECS Workshop2024-02-29T17:15:32-05:00
Go to Top